Disc Medicine (IRON) Stock Analysis

What Disc Medicine does

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Key metrics

ETFs linked to IRON

Broad-market and Healthcare sector ETFs an investor holding Disc Medicine is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IRON fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Disc Medicine?

Disc Medicine trades under the ticker IRON on NASDAQ.

Which exchange is IRON listed on?

IRON is listed on NASDAQ.

What sector does Disc Medicine operate in?

Disc Medicine is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IRON in a portfolio?

PortView shows IRON's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.